Elizabeth Cape, NP
Nurse Practitioner · Branson
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 8
Offices
8 locations · Skaggs Community Hospital Association · Cox-Monett Hospital Inc · Lester E Cox Medical Centers
Hospitals listed: Cox Medical Center Branson · Cox Medical Centers. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Elizabeth Cape’s office to ask if they take your plan before you enroll.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Cox Medical Center BransonBranson, MOAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of CoxHealth, which runs 5 hospitalsPatients rate it 3 of 5 · 71% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.367, Oct 2024 – Sep 2025
- Cox Medical CentersSpringfield, MOAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of CoxHealth, which runs 5 hospitalsPatients rate it 2 of 5 · 71% would definitely recommend itOverall rating: 3 of 5 starsWorse than the national rate — Pressure ulcer rate: 1.26 (0.73 to 1.79) · 9,354 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.525, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.419, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.466, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.204, Oct 2024 – Sep 2025
See every measure and the patient survey for Cox Medical Center Branson
Behind the star rating — Deaths: 0 better, 6 the same, 0 worse of 6 measures. Safety: 1 better, 4 the same, 0 worse of 5 measures. Readmissions: 2 better, 7 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.367 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.55 (0.49 to 2.6) · 219 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.98 (0.55 to 1.4) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 8.6 · 78 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12 · 162 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 12.4 · 182 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 17.5 · 257 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 13.2 · 167 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 1,758 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.24 (0.02 to 0.46) · 2,511 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.29 (0.08 to 0.5) · 2,505 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.34 (0.93 to 5.76) · 449 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.59 (0 to 3.28) · 46 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.16 (0.49 to 3.83) · 405 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.49 (0 to 16.58) · 45 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.95 (0.72 to 9.17) · 39 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.06 (0.55 to 3.57) · 73 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.72 (0 to 1.69) · 2,004 cases | No different | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 1.283 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.558 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.9 · 213 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20 · 309 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 5.5 · 134 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -15.9 · 202 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -8.6 · 261 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 14.2 · 462 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.3 (3.5 to 8.1) · 78 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.5 (7.5 to 14.6) · 78 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 18.8 · 179 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (9.6 to 16.6) · 668 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.6 to 1.2) · 271 cases | No different | Jan 2024 – Dec 2024 |
What patients said (623 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 71% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 77% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 72% |
| Doctors "always" listened carefully | 76% |
| Doctors "always" treated them with courtesy and respect | 84% |
| Patients who gave a rating of "9" or "10" (high) | 70% |
| Staff "always" explained new medications | 71% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 75% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 54% |
| "YES", patients would definitely recommend the hospital | 71% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 91% |
See every measure and the patient survey for Cox Medical Centers
Behind the star rating — Deaths: 0 better, 7 the same, 1 worse of 8 measures. Safety: 5 better, 3 the same, 0 worse of 8 measures. Readmissions: 1 better, 8 the same, 2 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Pressure ulcer rateComplications and deaths | 1.26 (0.73 to 1.79) · 9,354 cases | Worse | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.525 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.419 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.466 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.204 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.93 (0.11 to 1.76) · 2,249 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.2 (0.96 to 1.44) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 196.74 (158.57 to 234.92) · 159 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.5 · 207 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.3 · 234 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.3 · 231 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 13.4 · 439 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 12.3 · 641 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 14.1 · 874 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.5 · 6,663 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.22 (0.03 to 0.4) · 10,449 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.3 (0.12 to 0.48) · 10,960 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.47 (1.85 to 5.09) · 3,221 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2.58 (1.27 to 3.89) · 1,511 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.54 (1.31 to 3.78) · 3,065 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 10.41 (6.1 to 14.73) · 1,464 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 3.85 (1.03 to 6.67) · 1,462 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.29 (0.9 to 3.67) · 740 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.3 · 56 cases | None | Apr 2023 – Mar 2025 |
| SSI - Abdominal HysterectomyInfections | 0.802 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.602 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.9 · 544 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.8 · 767 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 49.1 · 271 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 28.8 · 475 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -5.5 · 670 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.8 · 1,301 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.1 (3.7 to 7.1) · 262 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11 (8.7 to 13.8) · 262 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 58 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.5 · 290 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.9 · 596 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.6 (10.2 to 15.7) · 3,588 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.9 to 1.2) · 1,811 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,234 patients answered, 23% of those asked)
| Cleanliness | 2 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 61% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 74% |
| Staff "always" explained | 53% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 84% |
| Doctors "always" explained things so they could understand | 68% |
| Doctors "always" listened carefully | 72% |
| Doctors "always" treated them with courtesy and respect | 80% |
| Patients who gave a rating of "9" or "10" (high) | 65% |
| Staff "always" explained new medications | 67% |
| Nurses "always" explained things so they could understand | 68% |
| Nurses "always" listened carefully | 69% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 49% |
| "YES", patients would definitely recommend the hospital | 71% |
| Staff "always" explained possible side effects | 39% |
| Yes, staff "did" give patients information about possible symptoms | 89% |
Original Medicare doctor bills
$21,977
Medicare paid this office $21,977 for 376 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Short return visit (20+ min) | 296 | $15,020 | $48 |
| Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | 13 | $895 | $69 |
| Short return visit | 28 | $867 | $31 |
| Return visit (30+ min) | 13 | $721 | $55 |
| X-ray of chest, 2 views | 46 | $659 | $14 |
See all 10 services
| Short return visit (20+ min) | 296 | $15,020 | $48 |
| Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | 13 | $895 | $69 |
| Short return visit | 28 | $867 | $31 |
| Return visit (30+ min) | 13 | $721 | $55 |
| X-ray of chest, 2 views | 46 | $659 | $14 |
| Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | 24 | $389 | $16 |
| Automated urinalysis test | 61 | $145 | $2 |
| Removal of impacted ear wax by washing | 12 | $101 | $8 |
| Blood glucose (sugar) level | 19 | $77 | $4 |
| Routine electrocardiogram (ecg) using at least 12 leads with tracing | 20 | $73 | $4 |
Who their Medicare patients are
376 Original Medicare patients in 2024. Average age 73 · Under 65 10% · 85 and older 9% · Women 58% · Also on Medicaid 8% · Health risk score 1.08. At or below the middle of the specialty; the typical nurse practitioner clinician is at 1.42.
Conditions among them: High blood pressure 75% · Diabetes 28% · Coronary heart disease 24% · Chronic kidney disease 24% · Depression 22% · COPD 19% · Atrial fibrillation 18% · Heart failure 14% · Cancer 14% · Stroke 6% · Dementia 5%.
The office billed $84,753, Medicare allowed $31,439 and paid $21,977; for 1,196 services of 44 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 376 | 1,196 | 73 | 1.08 | $84,753 | $21,977 |
| 2023 | 398 | 668 | 72 | 1.05 | $87,757 | $22,456 |
| 2022 | 240 | 349 | 71 | 1.18 | $58,816 | $13,407 |
| 2021 | 144 | 165 | 74 | 1.72 | $37,228 | $9,634 |
| 2020 | 28 | 40 | 70 | 1.19 | $13,982 | $2,587 |
| 2019 | 27 | 35 | 50 | 1.30 | $6,156 | $895 |
| 2018 | 22 | 24 | 59 | 1.17 | $4,437 | $494 |
| 2017 | 12 | 18 | 56 | 1.33 | $3,630 | $366 |
| 2016 | 19 | 25 | 57 | 1.93 | $4,547 | $670 |
| 2015 | 13 | 13 | 55 | 1.00 | $1,922 | $240 |
| 2014 | 15 | 18 | 55 | 1.11 | $3,189 | $366 |
| 2013 | 19 | 20 | 54 | 1.01 | $3,923 | $585 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 10 services
| Short return visit (20+ min) | 315 | $15,922 | $48 |
| Short return visit | 34 | $1,040 | $31 |
| Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | 28 | $969 | $35 |
| Return visit (30+ min) | 13 | $895 | $69 |
| Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | 30 | $486 | $16 |
| X-ray of chest, 2 views | 29 | $358 | $12 |
| Diphtheria, tetanus, and acellular pertussis vaccine (7 years or older) | 12 | $300 | $25 |
| Administration of vaccine | 12 | $124 | $10 |
| Automated urinalysis test | 43 | $97 | $2 |
| Routine electrocardiogram (ecg) using at least 12 leads with tracing | 24 | $84 | $3 |
2022: 7 services
| Short return visit (20+ min) | 90 | $4,697 | $52 |
| Emergency department visit with moderate level of medical decision making | 23 | $1,702 | $74 |
| Emergency department visit with low level of medical decision making | 28 | $1,093 | $39 |
| Short return visit (20+ min) | 28 | $894 | $32 |
| Short return visit | 14 | $428 | $31 |
| Emergency department visit with straightforward medical decision making | 14 | $355 | $25 |
| Automated urinalysis test | 17 | $38 | $2 |
2021: 5 services
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 30 | $2,637 | $88 |
| Emergency department visit with low level of medical decision making | 40 | $1,884 | $47 |
| Emergency department visit with moderate level of medical decision making | 11 | $894 | $74 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 11 | $511 | $46 |
| Emergency department visit with straightforward medical decision making | 17 | $481 | $28 |
2019: 2 services
| Emergency department visit with straightforward medical decision making | 14 | $487 | $30 |
| Emergency department visit for problem that may not require health care professional | 12 | $235 | $16 |
2018: 1 service
| Emergency department visit with straightforward medical decision making | 13 | $292 | $21 |
2016: 1 service
| Emergency department visit with straightforward medical decision making | 17 | $419 | $25 |
2015: 1 service
| Emergency department visit with straightforward medical decision making | 11 | $209 | $19 |
2013: 1 service
| Emergency department visit with straightforward medical decision making | 11 | $207 | $19 |
Medicaid work
$125,634 in 2024
Medicaid paid $125,634 for 1,792 billed services this clinician did in 2024, up to 129 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Short return visit (20+ min) | 1,314 | $118,646 |
| Infectious agent antigen detection by immunoassay with direct optical (ie, visual) observation; Streptococcus, group A | 235 | $3,788 |
| Short return visit | 25 | $1,571 |
| Culture, presumptive, pathogenic organisms, screening only | 157 | $783 |
| Radiologic examination, chest; 2 views | 35 | $715 |
| URINE PREGNANCY TEST | 13 | $103 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; automated, without microscopy | 13 | $27 |
| 2024 | 1,792 | 7 | 129 | $125,634 |
| 2023 | 2,199 | 12 | 108 | $156,642 |
| 2022 | 1,190 | 15 | 77 | $79,383 |
| 2021 | 43 | 2 | 14 | $1,436 |
| 2020 | 133 | 2 | 45 | $341 |
| 2019 | 703 | 2 | 54 | $1,265 |
| 2018 | 410 | 2 | 55 | $1,123 |
See the largest Medicaid services in earlier years
2023
| Short return visit (20+ min) | 1,458 | $138,609 |
| Infectious agent antigen detection by immunoassay with direct optical (ie, visual) observation; Streptococcus, group A | 392 | $6,963 |
| Infectious agent antigen detection by immunoassay technique (eg, enzyme immunoassay [EIA], enzyme-linked immunosorbent assay [ELISA], fluorescence immunoassay [FIA], immunochemiluminometric assay [IMCA]), qualitative or semiquantitative; severe acute respiratory syndrome coronavirus (eg, SARS-CoV, SARS-CoV-2 [COVID-19]) and influenza virus types A and B | 34 | $2,533 |
| EMERGENCY DEPARTMENT VISIT STRAIGHTFORWARD MDM | 13 | $1,810 |
| EMERGENCY DEPT VISIT MOD MDM | 14 | $1,558 |
| SARSCOV CORONAVIRUS AG IA | 32 | $1,546 |
| EMERGENCY DEPT VISIT LOW MDM | 21 | $1,501 |
| Short return visit | 15 | $942 |
| Culture, presumptive, pathogenic organisms, screening only | 174 | $901 |
| Culture, bacterial; aerobic isolate, additional methods required for definitive identification, each isolate | 12 | $130 |
| Culture, bacterial; quantitative colony count, urine | 17 | $108 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; automated, without microscopy | 17 | $40 |
2022
| Short return visit (20+ min) | 498 | $40,998 |
| EMERGENCY DEPT VISIT LOW MDM | 131 | $9,672 |
| EMERGENCY DEPARTMENT VISIT STRAIGHTFORWARD MDM | 90 | $6,694 |
| Infectious agent antigen detection by immunoassay technique (eg, enzyme immunoassay [EIA], enzyme-linked immunosorbent assay [ELISA], fluorescence immunoassay [FIA], immunochemiluminometric assay [IMCA]), qualitative or semiquantitative; severe acute respiratory syndrome coronavirus (eg, SARS-CoV, SARS-CoV-2 [COVID-19]) and influenza virus types A and B | 70 | $4,921 |
| Infectious agent detection by nucleic acid (DNA or RNA); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]), influenza virus types A and B, and respiratory syncytial virus, multiplex amplified probe technique | 33 | $4,728 |
| Hospital outpatient clinic visit for assessment and management of a patient | 52 | $4,505 |
| Short return visit | 74 | $4,139 |
| Infectious agent antigen detection by immunoassay with direct optical (ie, visual) observation; Streptococcus, group A | 116 | $1,854 |
| EMERGENCY DEPARTMENT VISIT MAY NOT REQ PHYS/QHP | 15 | $1,154 |
| Return visit (30+ min) | 15 | $426 |
| Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) and automated differential WBC count | 27 | $89 |
| Culture, presumptive, pathogenic organisms, screening only | 15 | $83 |
2021
| EMERGENCY DEPT VISIT LOW MDM | 30 | $1,012 |
| Service | 13 | $424 |
2020
| EMERGENCY DEPARTMENT VISIT STRAIGHTFORWARD MDM | 101 | $296 |
| EMERGENCY DEPARTMENT VISIT MAY NOT REQ PHYS/QHP | 32 | $46 |
2019
| EMERGENCY DEPARTMENT VISIT STRAIGHTFORWARD MDM | 434 | $902 |
| EMERGENCY DEPARTMENT VISIT MAY NOT REQ PHYS/QHP | 269 | $363 |
2018
| EMERGENCY DEPARTMENT VISIT STRAIGHTFORWARD MDM | 396 | $1,123 |
| OFFICE/OUTPATIENT VISIT NEW | 14 | $0 |
Drugs they prescribed that Part D paid
$7,445
Pharmacies billed $7,445 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 762) in 2024. At or below the middle of the specialty; the typical nurse practitioner clinician is at 0%.
729 generic and fewer than 11 brand-name prescriptions · $7,445 in drug cost · 382 antibiotic prescriptions to 345 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Neomycin-Polymyxin-Hc | 16 | $826 | $52 |
| Albuterol Sulfate Hfa | 40 | $718 | $17 |
| Cephalexin | 108 | $635 | $6 |
| Moxifloxacin | 13 | $518 | $40 |
| Doxycycline Monohydrate | 51 | $485 | $10 |
See all 14 drugs
| Neomycin-Polymyxin-Hc | 16 | $826 | $52 |
| Albuterol Sulfate Hfa | 40 | $718 | $17 |
| Cephalexin | 108 | $635 | $6 |
| Moxifloxacin | 13 | $518 | $40 |
| Doxycycline Monohydrate | 51 | $485 | $10 |
| Azithromycin | 90 | $285 | $3 |
| Prednisone | 135 | $246 | $2 |
| Amoxicillin-Clavulanate Potass | 34 | $205 | $6 |
| Cefdinir | 19 | $182 | $9 |
| Triamcinolone Acetonide | 32 | $160 | $5 |
| Fluticasone Propionate | 19 | $133 | $7 |
| Fluconazole | 20 | $105 | $4 |
| Ciprofloxacin | 15 | $87 | $5 |
| Sulfamethoxazole-Trimethoprim | 13 | $65 | $5 |
Year by year
| 2024 | 762 | 519 | 0% (0) | None | $7,445 |
| 2023 | 726 | 477 | 0% (0) | 5% | $10,214 |
| 2022 | 368 | 252 | 0% (0) | None | $5,729 |
| 2021 | 49 | 37 | None | None | $792 |
| 2020 | 38 | 25 | None | None | $946 |
| 2019 | 116 | 90 | 21% (24) | 18% | $2,127 |
| 2018 | 82 | 61 | 29% (24) | None | $1,264 |
| 2017 | 107 | 84 | 29% (31) | 11% | $1,878 |
| 2016 | 96 | 70 | 51% (49) | None | $1,821 |
| 2015 | 89 | 67 | 45% (40) | None | $1,512 |
| 2014 | 45 | 34 | 49% (22) | None | $899 |
| 2013 | 103 | 70 | 26% (27) | None | $1,508 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 13 drugs
| Albuterol Sulfate Hfa | 50 | $1,250 | $25 |
| Doxycycline Monohydrate | 77 | $845 | $11 |
| Moxifloxacin | 17 | $762 | $45 |
| Cephalexin | 63 | $499 | $8 |
| Valacyclovir | 11 | $447 | $41 |
| Azithromycin | 70 | $364 | $5 |
| Prednisone | 158 | $343 | $2 |
| Nitrofurantoin Mono-Macro | 20 | $342 | $17 |
| Doxycycline Hyclate | 25 | $316 | $13 |
| Amoxicillin-Clavulanate Potass | 28 | $280 | $10 |
| Cefdinir | 11 | $207 | $19 |
| Fluticasone Propionate | 18 | $161 | $9 |
| Triamcinolone Acetonide | 20 | $79 | $4 |
2022: 10 drugs
| Albuterol Sulfate Hfa | 33 | $1,110 | $34 |
| Doxycycline Hyclate | 43 | $497 | $12 |
| Cephalexin | 34 | $302 | $9 |
| Prednisone | 81 | $250 | $3 |
| Doxycycline Monohydrate | 12 | $176 | $15 |
| Amoxicillin-Clavulanate Potass | 13 | $134 | $10 |
| Azithromycin | 17 | $116 | $7 |
| Ibuprofen | 15 | $70 | $5 |
| Ciprofloxacin | 12 | $64 | $5 |
| Sulfamethoxazole-Trimethoprim | 12 | $53 | $4 |
2019: 3 drugs
| Hydrocodone-Acetaminophen | 22 | $144 | $7 |
| Prednisone | 14 | $105 | $8 |
| Ibuprofen | 11 | $84 | $8 |
2018: 2 drugs
| Hydrocodone-Acetaminophen | 19 | $133 | $7 |
| Cephalexin | 11 | $128 | $12 |
2017: 2 drugs
| Hydrocodone-Acetaminophen | 30 | $297 | $10 |
| Cephalexin | 12 | $137 | $11 |
2016: 2 drugs
| Hydrocodone-Acetaminophen | 44 | $531 | $12 |
| Ibuprofen | 12 | $109 | $9 |
2015: 1 drug
| Hydrocodone-Acetaminophen | 35 | $463 | $13 |
2014: 1 drug
| Hydrocodone-Acetaminophen | 19 | $166 | $9 |
2013: 1 drug
| Hydrocodone-Acetaminophen | 25 | $192 | $8 |
Money from drug and device companies
$31 in 2024
| 2024 | 2 | 2 | None | $31 |
| 2023 | 1 | 1 | None | $140 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Ortho Dermatologics a division of Bausch Health US | Cabtreo | $16 | 1 payment
|
| Genentech USA | Erivedge | $15 | 1 payment
|
See all 2 published payments
| Ortho Dermatologics a division of Bausch Health US | Meals · 2024-08-28 | Cabtreo | $16 |
| Genentech USA | Meals · 2024-04-09 | Erivedge | $15 |
See earlier years (2023)
2023: $140
| Neurocrine Biosciences | Ingrezza | $140 | 1 payment
|
Professional record
- NPI
- 1972787711
- Licence
- CA 611537, MO 202004196
- Group
- Skaggs Community Hospital Association · Cox-Monett Hospital Inc · Lester E Cox Medical Centers
- Gender
- Female
More record details
- Sole proprietor
- No
- Medicaid ID
- MO 420087056
- Taxonomy
- Nurse practitioner (363L00000X); Federal specialty code 364SE0003X (364SE0003X)
- Mailing address
- Po Box 802843, Kansas City, MO, 64180
- NPI first listed
- 2007-12-27
- NPI last updated
- 2025-06-23
- NPI record certified
- 2025-06-23
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 1000 E Primrose St Ste 170, Springfield, MO, 65807